Myelodysplastic Syndrome With Ring Sideroblasts: Clinical Trials

2 trials for Myelodysplastic Syndrome With Ring Sideroblasts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Myelodysplastic Syndrome With Ring Sideroblasts: new trials by email Literature Review of Myelodysplastic Syndrome With Ring Sideroblasts trials Research Report on Myelodysplastic Syndrome With Ring Sideroblasts

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biocollection in MyeloDysplastic Syndrome (P-MDS)
description of MDS pzatient cohort - Myelodysplastic Syndromes, Myelodysplastic Anemia
Not applicableRecruitingUniversity Hospital, Brest1502022-10-192026-06-25
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study - Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Phase 1 / Phase 2Active not recruitingNational Cancer Institute (NCI)1352006-11-222026-08-07

Narrower conditions

Myelodysplastic Syndromes (2)  ·  Anemia, Refractory (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Chromosome 5q Deletion Syndrome (1)  ·  Chromosome Aberrations (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Azacitidine (1)  ·  Vorinostat (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  University Hospital, Brest (1)

Countries

France (1)  ·  United States (1)

Top investigators

Lewis R Silverman (1)  ·  Nathalie Douet-Guilbert, MD,PhD (1)

NIH funding

N01CM17103 (1), N01CM62204 (1), P30CA013330 (1)